15,000 Dispensaries: 79% of Americans Now Live Near a Cannabis Shop

A Retail Footprint That Defies Its Federal Status

There are nearly 15,000 cannabis dispensaries operating in the United States. According to Pew Research Center data published May 26, 2026, 79% of American adults now live in a county that has at least one cannabis dispensary — a statistic that would have been unthinkable a decade ago and one that says more about the state of American cannabis policy than any legislative debate.

To put that number in context, there are roughly 13,000 McDonald's locations in the U.S., about 9,000 Starbucks, and approximately 9,500 CVS Pharmacy stores. Cannabis dispensaries, a product category that remains a Schedule I controlled substance for most federal purposes, have quietly built a retail network that rivals some of America's most established chains.

The Geography of Access

The 79% figure masks enormous geographic variation. In states with mature legal markets — California, Colorado, Michigan, Oregon, Washington — dispensary density is high enough that most residents have multiple options within a short drive. New York City alone has 270 dispensaries, contributing nearly $241 million in sales through the first quarter of 2026.

But the distribution is far from uniform. Rural areas in legal states often have fewer dispensaries per capita than urban centers, a pattern that mirrors broader retail desertification in rural America. And in states without legal markets — primarily in the South and parts of the Plains states — the nearest dispensary may be hundreds of miles away across state lines.

The 21% of Americans who do not live in a county with a dispensary are concentrated in a handful of states: Idaho, Wyoming, Kansas, and parts of the Deep South where neither medical nor recreational cannabis programs exist. But even in these holdout states, border communities benefit from proximity to legal markets in neighboring states.

How 15,000 Happened

The dispensary count has been on a steep growth curve since 2020. Several factors converged to produce the current number.

State-Level Legalization Waves

The most obvious driver is the steady expansion of legal markets. Twenty-four states and the District of Columbia now have operational recreational cannabis programs, and 38 states have some form of medical cannabis. Each new state that comes online adds dozens to hundreds of licensed retail locations within a year or two of launch.

Ohio's market is a recent example. Since launching adult-use sales in August 2024, the state has reached 204 dual-use dispensaries and generated over $1.1 billion in combined sales. New York, despite a rocky rollout plagued by licensing delays and illicit market competition, has grown to more than 600 dispensaries. Minnesota's market launched in 2025 and is already projecting $430 million in sales.

Medical Program Maturation

States that started with restrictive medical programs have gradually expanded both qualifying conditions and the number of licensed dispensaries. Kentucky's medical program opened its first dispensaries in 2026 after a five-year wait since legalization. Alabama, one of the last Southern holdouts, finally saw dispensaries open this year. Iowa doubled its medical dispensary count through HF 990, specifically targeting rural access.

These medical expansions add to the national dispensary count even in states where recreational cannabis remains illegal.

License Cap Increases

Several mature markets have increased their dispensary license caps in response to demand. Illinois is transitioning to a unified licensing framework under SB 4015. New York has aggressively licensed both social equity and general applicants. Even states with historically tight caps — like Ohio, which briefly imposed a 400-dispensary limit under SB 56 — are adjusting upward as market data demonstrates unmet demand.

The Dispensary Desert Problem

While 79% access is impressive, the 21% who lack local access deserve attention. Cannabis deserts — areas where legal consumers have no reasonable physical access to a dispensary — persist for several reasons.

Local opt-out provisions are the primary cause. Most states allow individual municipalities to ban dispensaries within their borders, and many have done so. In Ohio, 163 towns and cities have enacted moratoriums or permanent bans on adult-use cannabis establishments. In New Jersey, more than 70% of municipalities initially opted out of allowing cannabis businesses. These opt-outs create a patchwork where a state may be "legal" on paper but significant portions of its population have no local access.

Zoning restrictions compound the problem. Even in municipalities that allow dispensaries, zoning rules that mandate buffer distances from schools, churches, parks, daycare centers, and residential zones can effectively eliminate all viable locations in small towns. A 1,000-foot buffer from schools and churches in a rural village with three churches and a school may leave zero compliant parcels.

What Access Means for Consumers

The practical impact of dispensary density varies by population segment.

For recreational consumers, high dispensary density means price competition, product variety, and convenience. Markets with more dispensaries per capita tend to have lower prices and better selection — a straightforward effect of competition. Same-day delivery, available in 24 states as of 2026, extends access even further.

For medical patients, dispensary access is a healthcare access issue. Patients using cannabis for chronic pain, seizure disorders, or other qualifying conditions need reliable, consistent access to specific products and formulations. A 90-minute drive to the nearest dispensary is not merely inconvenient — it's a barrier to medication adherence that would be unacceptable for any other prescription.

For older adults — the fastest-growing consumer demographic — proximity matters disproportionately. Mobility limitations, transportation challenges, and the simple inconvenience of a long drive mean that seniors are less likely to become or remain cannabis consumers if their nearest dispensary is far away.

The Illicit Market Counterweight

One of the persistent arguments for increasing dispensary density is its impact on the illicit market. The logic is straightforward: when legal cannabis is convenient, affordable, and reliable, consumers shift away from unlicensed sources.

The data broadly supports this. New York's rapid dispensary expansion has correlated with a measurable decline in smoke-shop cannabis sales. Ohio's hemp ban under SB 56 pushed an estimated 20-30% more consumers into licensed dispensaries, partly by eliminating unregulated hemp-derived THC products that competed with the legal market.

But the relationship is not perfectly linear. California, with the most dispensaries of any state, still struggles with a large illicit market — driven primarily by price competition from unlicensed growers who don't pay the state's heavy excise taxes. Dispensary density helps, but it's not sufficient on its own without competitive pricing and effective enforcement against illicit operators.

The Employment Footprint

Nearly 15,000 dispensaries translates into a substantial employment base. The average dispensary employs 15-25 people across management, budtending, security, compliance, and administrative roles. That puts the dispensary-level cannabis retail workforce at roughly 225,000 to 375,000 people — not counting cultivation, processing, distribution, and ancillary services.

These jobs exist in communities across the socioeconomic spectrum, often in neighborhoods where retail employment opportunities are limited. Social equity licensing programs in states like Illinois, New York, and New Jersey have specifically targeted dispensary licenses toward applicants from communities disproportionately harmed by prohibition.

What Comes Next

The dispensary count will continue to grow as new states launch programs and existing markets expand licensing. But the rate of growth will likely moderate as markets mature and competitive pressures thin out underperforming operators.

The DEA hearing beginning June 29 on broader marijuana rescheduling could accelerate dispensary proliferation if recreational cannabis moves to Schedule III. Federal normalization would reduce banking barriers, ease real estate challenges, and potentially open interstate commerce — all of which would lower the cost of opening and operating a dispensary.

The most transformative change would be federal legalization that preempts local opt-outs, but that remains politically distant. In the near term, the dispensary map will continue to be shaped by the patchwork of state laws, local politics, and market economics that have produced the current landscape.

The headline number — 15,000 dispensaries, 79% access — represents a remarkable achievement for an industry that operates in defiance of federal prohibition. It also represents an incomplete project. Until every American who wants legal access to cannabis has it within reasonable distance, the map has gaps that matter.